Embecta Corp.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Embecta Corp.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 3.1 times its market value (net debt). Lower than 98% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 20.2 times by its yearly operating cash. Higher than 90% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 5.7 times. Higher than 89% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Sep 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$121Over the last 3 years, every $100 of reported profit came with $121 of operating cash.
Lower than 71% of Healthcare companies in United States.
Self-Funding Ratio
5.7×Over the last 3 years its own operating cash covered its investment spending (capex) 5.7 times.
Higher than 89% of Healthcare companies in United States.
Cash Locked Ratio
$21For every $100 of sales, $21 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $11 tied up three years earlier.
Less money tied up than 55% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by -4% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
-4% / +0%In 3 years sales changed by -4% while total assets changed by +0%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
20.2×Debt due within a year is covered 20.2 times by its yearly operating cash.
Higher than 90% of Healthcare companies in United States.
Cash Cushion Ratio
3.1× debtDebt, after subtracting cash, is 3.1 times its market value (net debt).
Lower than 98% of Healthcare companies in United States.
Tangible Assets Ratio
98%Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 84% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Embecta Corp. owes $1.48 for every $1 it owns. Net profit rose 22% in the year to Sep 2025, and shrank 25% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Sep 2025.
P/E ratio
4.7Investors pay $4.7 for every $1 of Embecta Corp.'s yearly profit, lower than 86% of Healthcare companies in United States.
P/B ratio
-0.63Embecta Corp.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$389 MThe total market value of all of Embecta Corp.'s shares at today's price (share price × number of shares), larger than 51% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeEmbecta Corp.'s net worth is negative ($613 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.48×Embecta Corp. owes $1.48 for every $1 it owns, so it owes more than it owns, higher than 94% of Healthcare companies in United States.
Dividend yield
0.60%Embecta Corp. pays 0.60% of its share price as dividends a year, lower than 71% of dividend-paying Healthcare companies in United States.
Revenue growth
-4%Revenue fell 4% in the year to Sep 2025, and shrank 1% a year on average over 3 years.
Profit growth
+22%Net profit rose 22% in the year to Sep 2025, and shrank 25% a year on average over 3 years.
Profit margin
8.8%Embecta Corp. keeps $9 of every $100 of revenue as net profit.
Cash quality
2.0×Cash from Embecta Corp.'s business was 2.0× its reported profit in the year to Sep 2025 — its profit turned into cash.
Interest cover
2.8×Embecta Corp.'s operating profit covered its interest costs 2.8 times in the year to Sep 2025.
Cash vs debt
Net debtEmbecta Corp. had $1.2 B more debt than cash (net debt) at Sep 2025.
Questions
What is Embecta Corp.'s P/E ratio?
Investors pay $4.7 for every $1 of Embecta Corp.'s yearly profit, lower than 86% of Healthcare companies in United States.
How much does Embecta Corp. owe compared with what it owns?
Embecta Corp. owes $1.48 for every $1 it owns, so it owes more than it owns, higher than 94% of Healthcare companies in United States.
Does Embecta Corp. pay a dividend?
Yes. Embecta Corp. pays 0.60% of its share price as dividends a year, lower than 71% of dividend-paying Healthcare companies in United States.
Is Embecta Corp.'s revenue growing?
Revenue fell 4% in the year to Sep 2025, and shrank 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.